Literature DB >> 15134138

Blood phospholipid fatty acid analysis of adults with and without attention deficit/hyperactivity disorder.

Genevieve S Young1, Nicole J Maharaj, Julie A Conquer.   

Abstract

Several psychiatric disorders, including juvenile Attention Deficit/Hyperactivity Disorder (ADHD), have been associated with abnormalities of certain long-chain PUFA (LCPUFA). Despite this reported association, the FA levels of patients with the adult form of ADHD have not previously been evaluated. In this study we measured the total blood phospholipid FA concentrations in 35 control subjects and 37 adults with ADHD symptoms to determine whether adults with ADHD symptoms would show abnormalities of FA relative to control subjects. In the serum phospholipids, adults with ADHD symptoms had significantly lower levels of total saturated, total polyunsaturated, and total omega-6 (n-6) FA, as well as the omega-3 (n-3) LCPUFA DHA (22:6n-3), and significantly higher levels of total monounsaturated FA and the n-3 LCPUFA docosapentaenoic acid (22:5n-3). In the erythrocyte membrane phospholipids, adults with ADHD symptoms had significantly lower levels of total PUFA, total n-3 FA, and DHA, and significantly higher levels of total saturated FA. Neither serum nor erythrocyte membrane phospholipid DHA was related to ADHD symptom severity (as assessed by the Amen questionnaire) in ADHD subjects. Although the exact cause of these variations is unknown, both environmental and genetic factors may be involved.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15134138     DOI: 10.1007/s11745-004-1209-3

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  64 in total

1.  A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties.

Authors:  Alexandra J Richardson; Basant K Puri
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2002-02       Impact factor: 5.067

2.  Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.

Authors:  A L Stoll; W E Severus; M P Freeman; S Rueter; H A Zboyan; E Diamond; K K Cress; L B Marangell
Journal:  Arch Gen Psychiatry       Date:  1999-05

3.  Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients.

Authors:  R Edwards; M Peet; J Shay; D Horrobin
Journal:  J Affect Disord       Date:  1998-03       Impact factor: 4.839

Review 4.  Attention-deficit/hyperactivity disorder: an update.

Authors:  Raymond Pary; Susan Lewis; Paul R Matuschka; Steven Lippmann
Journal:  South Med J       Date:  2002-07       Impact factor: 0.954

Review 5.  Attention deficit hyperactivity disorder in adults: a guide for the primary care physician.

Authors:  Hal Elliott
Journal:  South Med J       Date:  2002-07       Impact factor: 0.954

Review 6.  Omega-3 fatty acids in health and disease and in growth and development.

Authors:  A P Simopoulos
Journal:  Am J Clin Nutr       Date:  1991-09       Impact factor: 7.045

Review 7.  Membrane lipid composition and cellular function.

Authors:  A A Spector; M A Yorek
Journal:  J Lipid Res       Date:  1985-09       Impact factor: 5.922

8.  Fatty acid compositions of serum phospholipids of postmenopausal women: a comparison between Greenland Inuit and Canadians before and after supplementation with fish oil.

Authors:  Ken D Stark; Gert Mulvad; Henning S Pedersen; Eek J Park; Eric Dewailly; Bruce J Holub
Journal:  Nutrition       Date:  2002 Jul-Aug       Impact factor: 4.008

9.  Decreased phospholipase A2 activity in the brain and in platelets of patients with Alzheimer's disease.

Authors:  W F Gattaz; N J Cairns; R Levy; H Förstl; D F Braus; A Maras
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

10.  Degradation of specific polyunsaturated fatty acids in red blood cells stored at -20 degrees C proceeds faster in patients with schizophrenia when compared with healthy controls.

Authors:  Helen Fox; Brian M Ross; Douglas Tocher; David Horrobin; Iain Glen; David St Clair
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2003-11       Impact factor: 4.006

View more
  21 in total

1.  Omega-3 fatty acid and ADHD: blood level analysis and meta-analytic extension of supplementation trials.

Authors:  Elizabeth Hawkey; Joel T Nigg
Journal:  Clin Psychol Rev       Date:  2014-06-02

Review 2.  Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis.

Authors:  Michael H Bloch; Ahmad Qawasmi
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2011-08-12       Impact factor: 8.829

3.  Omega-3 Supplementation and the Neural Correlates of Negative Affect and Impulsivity: A Double-Blind, Randomized, Placebo-Controlled Trial in Midlife Adults.

Authors:  Annie T Ginty; Matthew F Muldoon; Dora C H Kuan; Brittney Schirda; Thomas W Kamarck; J Richard Jennings; Stephen B Manuck; Peter J Gianaros
Journal:  Psychosom Med       Date:  2017-06       Impact factor: 4.312

Review 4.  Deciphering the role of docosahexaenoic acid in brain maturation and pathology with magnetic resonance imaging.

Authors:  Robert K McNamara
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2012-04-21       Impact factor: 4.006

5.  Role of Long-Chain Omega-3 Fatty Acids in Psychiatric Practice.

Authors:  Robert K McNamara; Jeffrey R Strawn
Journal:  PharmaNutrition       Date:  2013-04

Review 6.  Docosahexaenoic acid and cognitive function: Is the link mediated by the autonomic nervous system?

Authors:  Kathleen M Gustafson; John Colombo; Susan E Carlson
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2008-10-18       Impact factor: 4.006

7.  Classical maple syrup urine disease and brain development: principles of management and formula design.

Authors:  Kevin A Strauss; Bridget Wardley; Donna Robinson; Christine Hendrickson; Nicholas L Rider; Erik G Puffenberger; Diana Shellmer; Diana Shelmer; Ann B Moser; D Holmes Morton
Journal:  Mol Genet Metab       Date:  2010-01-12       Impact factor: 4.797

Review 8.  Significance of long-chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children.

Authors:  Jan Philipp Schuchardt; Michael Huss; Manuela Stauss-Grabo; Andreas Hahn
Journal:  Eur J Pediatr       Date:  2009-08-12       Impact factor: 3.183

9.  Omega-3 fatty acids are related to abnormal emotion processing in adolescent boys with attention deficit hyperactivity disorder.

Authors:  Rachel V Gow; Alexander Sumich; Frederic Vallee-Tourangeau; Michael Angus Crawford; Kebreab Ghebremeskel; Allain A Bueno; Joseph R Hibbeln; Eric Taylor; Daniel A Wilson; Katya Rubia
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2013-05-06       Impact factor: 4.006

10.  Malondialdehyde levels in adult attention-deficit hyperactivity disorder.

Authors:  Mahmut Bulut; Salih Selek; H Serdar Gergerlioglu; Haluk A Savas; H Ramazan Yilmaz; Murat Yuce; Giyasettin Ekici
Journal:  J Psychiatry Neurosci       Date:  2007-11       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.